Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ginkgo Bioworks Holdings Inc shares valued at $220,030 were sold by DEKKERS MARIJN E on May 16 ’24. At $0.83 per share, DEKKERS MARIJN E sold 265,000 shares. The insider’s holdings dropped to 5,515,364 shares worth approximately $3.86 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Sankar Shyam purchased 625,000 shares, netting a total of over 514,750 in proceeds. Following the buying of shares at $0.82 each, the insider now holds 2,356,874 shares.
Before that, SLOAN HARRY had added 297,619 shares to its account. In a trade valued at $271,815, the Director bought Ginkgo Bioworks Holdings Inc shares for $0.91 each. Upon closing the transaction, the insider’s holdings increased to 297,619 shares, worth approximately $0.5 million.
As published in a research note from BTIG Research on May 15, 2024, Ginkgo Bioworks Holdings Inc [DNA] has been rated down from a Neutral to a Sell. Analysts at William Blair downgraded the stock from ‘”a Mkt perform”‘ to ‘”an Underperform”‘ outlook in a report released in early May. As of November 14, 2023, Raymond James has decreased its “an Outperform” rating to a “Mkt perform” for DNA. Earlier on November 09, 2023, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for DNA stock which previously was a “a Buy”.
Analyzing DNA Stock Performance
During the last five days, there has been a drop of approximately -16.46%. Over the course of the year, Ginkgo Bioworks Holdings Inc shares have dropped approximately -58.52%. Shares of the company reached a 52-week high of $1.7200 on 01/02/24 and a 52-week low of $0.6900 on 05/22/24. A 50-day SMA is recorded $0.9655, while a 200-day SMA reached $1.4118. Nevertheless, trading volume fell to 47.4 million shares from 49.1 million shares the previous day.
Support And Resistance Levels for Ginkgo Bioworks Holdings Inc (DNA)
According to the 24-hour chart, there is a support level at 0.6807, which, if violated, would cause prices to drop to 0.6603. In the upper region, resistance lies at 0.7307. The next price resistance is at 0.7603. RSI (Relative Strength Index) is 35.74 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1127, which suggests the price will decrease in the coming days. Percent R is at 96.76%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
